Hypermetabolism in the hippocampal formation of cognitively impaired patients indicates detrimental maladaptation-Reference-Cited by-同舟云学术

Hypermetabolism in the hippocampal formation of cognitively impaired patients indicates detrimental maladaptation

Published:2018-05 Issue: Volume:65 Page:41-50
ISSN:0197-4580
Container-title:Neurobiology of Aging
language:en
Short-container-title:Neurobiology of Aging

Author:

Apostolova Ivayla,Lange Catharina^ORCID,Mäurer Anja,Suppa Per,Spies Lothar,Grothe Michel J.,Nierhaus Till,Fiebach Jochen B.,Steinhagen-Thiessen Elisabeth,Buchert R.

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Developmental Biology,Clinical Neurology,Ageing,General Neuroscience

Reference65 articles.

1. The association of glucose metabolism and eigenvector centrality in Alzheimer's disease;Adriaanse;Brain Connect.,2016

2. Challenges in screening and recruitment for a neuroimaging study in cognitively impaired geriatric inpatients;Apostolova;J. Alzheimers Dis.,2017

3. Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment;Bakker;Neuron,2012

4. Role of frontal versus temporal cortex in verbal fluency as revealed by voxel-based lesion symptom mapping;Baldo;J. Int. Neuropsychol. Soc.,2006

5. Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types;Baumgartner;J. Neurol.,2013

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerebral glucose metabolism in Alzheimer's disease;Cortex;2024-10

2. Impaired microglial glycolysis promotes inflammatory responses after intracerebral haemorrhage via HK2-dependent mitochondrial dysfunction;Journal of Advanced Research;2024-08

3. Bioenergetic phenotype of hippocampal neurons in various inbred mouse strains;2024-05-14

4. The diagnostic and prognostic value of tau‐PET in amnestic MCI with different FDG‐PET subtypes;Annals of Clinical and Translational Neurology;2024-03-29

5. Radionuclide Imaging of the Neuroanatomical and Neurochemical Substrate of Cognitive Decline in Parkinson’s Disease;Nuclear Medicine and Molecular Imaging;2024-02-15